Evidence map›Paper›PMID 41120471›Full record

ArticleScientific reports2025

Machine learning improves detection of alpha thalassemia carriers compared to clinical features.

Elmira Mohammadi, Mohsen Rastegar, Amir Jamshidnezhad, Amirabbas Azizi

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Diagnosis and classification of thalassemia disease using machine learning: Comparative analysis of traditional models and a novel hybrid approach.Technology and health care : official journal of the European Society for Engineering and Medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elmira MohammadiThalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Mohsen RastegarDepartment of Non-Communicable Diseases (Genetics), Shiraz University of Medical Sciences, Shiraz, Iran.
Amir JamshidnezhadThalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Amirabbas AziziThalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. amirabbas.azizi@gmail.com.

Funding

Ahvaz Jundishapur University of Medical Sciences Th-0206
6 · The paper itself

Abstract

Alpha-thalassemia is a widespread genetic disorder, and accurately distinguishing between alpha-plus (α⁺) and alpha-zero (α⁰) types is critical for effective screening and management. This study developed and evaluated machine learning models to classify α⁺ and α⁰ carriers based on hematological parameters. A dataset of 956 cases was analyzed, including variables such as red blood cell (RBC) count, hemoglobin (Hb) level, and RBC indices. Feature selection identified the most predictive markers, and five machine learning models were trained and compared. The stacking ensemble model demonstrated the best performance, achieving 94% accuracy and a high F1-score. Key predictors included RBC count, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC). Correlation analysis revealed strong interrelationships among RBC indices, while platelet (PLT) and white blood cell (WBC) parameters had moderate associations. These findings suggest that machine learning, particularly ensemble methods, can enhance the detection of alpha-thalassemia carriers. The development of models based on both data-driven and clinical features provides a flexible framework for screening and could support more personalized approaches in future research.

Indexed as

alpha-ThalassemiaHeterozygoteMachine LearningAdolescentAdultErythrocyte CountErythrocyte IndicesFemaleHemoglobinsHumansMaleMiddle AgedYoung AdultHemoglobinsAlpha-thalassemiaCRISP-DMMachine learningPredictive modelingThalassemia screening

Identifiers

PMID41120471
PMCPMC12541011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.